ABEO Abeona Therapeutics Inc.

NASDAQ
$2.60

Abeona Therapeutics Inc. (ABEO) is expected to report earnings on February 8, 2027, before the market open. The consensus earnings estimate is a loss of $0.25 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -28.2% since its last earnings release on November 9, 2026.

Abeona Therapeutics Beat Consensus Estimates
Monday, November 9, 2026 · 6:35 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 8
Monday · 7:30 AM ET
Earnings Whisper
-
vs ($0.25)
Rev est $14.62M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.46

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Abeona Therapeutics Inc.

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.